RT Journal Article
SR Electronic
T1 Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: a cross sectional study, Israel, March-December 2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.30.21268538
DO 10.1101/2021.12.30.21268538
A1 Blumberg, Yair
A1 Edelstein, Michael
A1 Jabal, Kamal Abu
A1 Golan, Ron
A1 Perets, Yuval
A1 Saad, Musa
A1 Levinas, Tatyana
A1 Dabbah, Saleem
A1 Israeli, Zeev
A1 Yacoubi, Salah
A1 Raya, Alaa Abu
A1 Amital, Anat
A1 Halabi, Majdi
YR 2022
UL http://medrxiv.org/content/early/2022/01/02/2021.12.30.21268538.abstract
AB There is increasing evidence that patients who were infected with SARS-CoV-2 may experience adverse health outcomes months after the acute infection has resolved including reduction in aerobic capacity and fatigue. In this study, we compared aerobic capacity and exercise performance of 28 unvaccinated participants to 15 vaccinated ones who performed a symptom limited cardio-pulmonary exercise test (CPET) after acute COVID-19. We identified a significant difference in aerobic capacity between vaccinated and unvaccinated individuals, with a lower V’O2 peak percentage of predicted in the unvaccinated group. In addition, the unvaccinated group had a reduction in the peak-exercise heart rate and lower ventilation values. Our results suggest objective limitations to exercise capacity in the months following acute COVID19 illness, mitigated by vaccinationCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any external fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of Ziv Medical Centre approved the study, approval 0100-20-ZIVI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript